Metabolon Collaborates with Trajan on Microsampling Solutions for Metabolomics Research
The power of advanced metabolomic analytical techniques can now be applied to a broader array of diverse academic and commercial life science research
Life science research studies are frequently constrained by their inability to easily and efficiently secure adequate, stable biological samples. Mitra devices offer precision via a volumetric absorptive microsampling method that is minimally invasive and user-friendly. This microsampling technique is ideal when working in a preclinical research lab setting. Smaller microliter sample volumes also enable research not possible with standard blood collection techniques, such as sample collection at athletic events, in-home or home-bound settings, when working with vulnerable populations, and at remote field research locations.
"This democratizes the ability to collect sufficient, stable blood samples for metabolomic analysis. Our work with Trajan will help researchers access patients more easily through decentralized trials and foster greater adoption of metabolomics," said
"Through this partnership, we are breaking down the traditional sample collection barriers in metabolomic analysis, enabling researchers to access a broader and more diverse spectrum of patients and clinical trial or research participants," said
To learn more about metabolomics and how Metabolon is partnering with Trajan to take advantage of Neoteryx Mitra collection devices based on VAMS technology, please visit the Metabolon website or Neoteryx website.
About Metabolon
Metabolon, Inc. is the global leader in metabolomics, with a mission to deliver biochemical data and insights that expand and accelerate the impact of life sciences research. Over 20 years, 10,000+ projects, 3,000+ publications, and ISO 9001:2015, CAP, and CLIA certifications, Metabolon has developed industry-leading scientific, technology, and bioinformatics techniques. Metabolon's Global Discovery Panel is enabled by the world's largest proprietary metabolomics reference library. Metabolon's industry-leading data and translational science expertise help customers and partners address some of the most challenging and pressing questions in the life sciences, accelerating research and enhancing development success. The company offers scalable, customizable metabolomics and lipidomics solutions supporting customer needs from discovery through clinical trials and product life-cycle management. For more information, please visit www.metabolon.com and follow us on LinkedIn and Twitter.
About Trajan Scientific and Medical
Trajan is a global developer and manufacturer of analytical and life sciences products and devices founded to enrich personal health through scientific tools and solutions. We aim to support science that benefits people. Trajan's products and solutions are used in the analysis of biological, food, and environmental samples. Trajan has a portfolio and pipeline of new technologies which support the move towards decentralized personalized data-based healthcare. Trajan comprises more than 680 people with seven manufacturing sites across the US,
Media Inquiries:
[email protected]
Director, Corporate Communications
Metabolon
[email protected]
WE Communications
Trajan Scientific and Medical
View original content to download multimedia:https://www.prnewswire.com/news-releases/metabolon-collaborates-with-trajan-on-microsampling-solutions-for-metabolomics-research-301992744.html
SOURCE Metabolon, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rosnet Trades "The Cave" for a New Kansas City Headquarters Built for Its Next Chapter of Growth
- In HelloNation, Montessori Education Expert Madelynn Van Den Heuvel Explains How Independence Develops in Children
- CBS ArcSafe® Adds Wireless Operation and Milwaukee Power to Chicken Switch® RSK-DS10 for DS-Style Circuit Breakers
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share